Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 1
R&D Momentum
51/100
Pipeline Velocity
27/100
Trial Completion Rate
100/100
Pipeline Concentration
100/100
Pipeline Freshness
63/100
Activity
Last 14 days
The Effect of Breast Self-Examination Education Using Visual Materials on Breast Cancer Awareness and Health Motivation Among Illiterate Women of Reproductive Age: A Study in Diyarbakır, Türkiye
Problematic Smartphone and Internet-Use Symptoms, Handgrip Strength, and Digit Ratio in University Students From Different Regional Backgrounds
Examining the Relationships Between Interoceptive Awareness, Perceived Stress, and Physical Performance Indicators: The Moderator Role of Gender and Sport Type
Evaluation of the Effects of Hyaluronic Acid and Albumin-PRF as Adjuncts to Non-Surgical Periodontal Treatment on Clinical and Biochemical Parameters
Associations of Core Endurance With Medicine Ball Throw Performance and Static Balance in Young Male Judokas: A Cross-Sectional Study
Effects of a Cognitively Enriched Playful Physical Activity Program on Executive Functions and School Readiness in Preschool Children
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)